| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
|
N Engl J Med
|
1991
|
2.40
|
|
2
|
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.
|
Blood
|
1993
|
2.25
|
|
3
|
Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.
|
Leukemia
|
2004
|
1.64
|
|
4
|
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
|
Hematol Oncol
|
1984
|
1.17
|
|
5
|
Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
|
Klin Wochenschr
|
1987
|
1.00
|
|
6
|
Why not adhere to the original Kiel classification?
|
Lancet
|
1980
|
1.00
|
|
7
|
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
|
Blood
|
1997
|
0.96
|
|
8
|
[Lymphocyte in chronic lymphatic leukemia].
|
Blut
|
1975
|
0.92
|
|
9
|
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
|
Br J Cancer
|
2005
|
0.92
|
|
10
|
Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.
|
Eur J Haematol
|
1995
|
0.91
|
|
11
|
Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.
|
Klin Wochenschr
|
1987
|
0.85
|
|
12
|
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
|
Leukemia
|
1996
|
0.84
|
|
13
|
[Strategies in the treatment of non-Hodgkin's lymphomas].
|
Internist (Berl)
|
1986
|
0.84
|
|
14
|
Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients.
|
Oncology
|
1996
|
0.83
|
|
15
|
Effects of recombinant human interleukin-3 in aplastic anemia.
|
Blood
|
1990
|
0.82
|
|
16
|
Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.
|
Blut
|
1988
|
0.82
|
|
17
|
Efficacy of doxorubicin in prolymphocytic leukaemia.
|
Br J Haematol
|
1979
|
0.81
|
|
18
|
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia.
|
Ann Hematol
|
2000
|
0.80
|
|
19
|
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma.
|
Cancer
|
1989
|
0.78
|
|
20
|
Lymphoplasmacytic/lymphoplasmacytoid lymphoma: a clinical entity distinct from chronic lymphocytic leukaemia?
|
Blut
|
1981
|
0.78
|
|
21
|
Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classification.
|
N Engl J Med
|
1979
|
0.78
|
|
22
|
Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange.
|
Semin Thromb Hemost
|
1995
|
0.77
|
|
23
|
Lysosomal acid phosphatase: difference between normal and chronic lymphocytic leukaemia T and B lymphocytes.
|
Blut
|
1976
|
0.77
|
|
24
|
Lysosomal acid hydrolases in isolated normal and chronic lymphocytic leukemia (CLL) T- and B-lymphocytes.
|
Haematol Blood Transfus
|
1977
|
0.77
|
|
25
|
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.
|
Exp Hematol
|
1998
|
0.76
|
|
26
|
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
|
Ann Oncol
|
1991
|
0.75
|
|
27
|
Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia.
|
Blood
|
1986
|
0.75
|
|
28
|
Aplastic anaemia: clinical course and histologic picture.
|
Bibl Haematol
|
1978
|
0.75
|
|
29
|
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
|
Onkologie
|
1989
|
0.75
|
|
30
|
Long-lasting remission of hairy cell leukemia after eight weeks' therapy with low-dose alpha-(leucocyte-)interferon.
|
Blut
|
1985
|
0.75
|
|
31
|
[Postsplenectomy sepsis (overwhelming postsplenectomy infection (OPSI) syndrome)].
|
Dtsch Med Wochenschr
|
1995
|
0.75
|
|
32
|
[Bone marrow biopsy investigation: an important prognostic factor in aplastic anaemia (author's transl)].
|
Med Klin
|
1977
|
0.75
|
|
33
|
[Chronic lymphocytic leukemia as a diagnostic error in neoplasms and chronic-inflammatory processes].
|
Med Welt
|
1979
|
0.75
|
|
34
|
Extramedullary manifestation of the blastic phase of chronic myelocytic leukemia: A chromosome study.
|
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol
|
1975
|
0.75
|
|
35
|
[High-dose cytarabine treatment: a promising therapy modality in acute resistant myeloid leukemias in recurrence].
|
Onkologie
|
1985
|
0.75
|
|
36
|
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
|
Onkologie
|
1988
|
0.75
|
|
37
|
[Chronic lymphatic leukemia (CLL) as a missed diagnosis in cancer].
|
Verh Dtsch Ges Inn Med
|
1978
|
0.75
|
|
38
|
[The Sjögren syndrome. A contribution to the differential diagnosis of chronic abacterial interstitial nephritis].
|
Med Welt
|
1982
|
0.75
|
|
39
|
Regulation of the T cell receptor-alpha mRNA expression in the human lymphoblastic T cell line CEM.
|
Exp Hematol
|
1993
|
0.75
|
|
40
|
[Prognosis of plasmacytoma].
|
Lebensversicher Med
|
1985
|
0.75
|
|
41
|
[Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas].
|
Strahlenther Onkol
|
1999
|
0.75
|
|
42
|
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.
|
Blut
|
1981
|
0.75
|
|
43
|
[Chemotherapy in non-Hodgkin lymphoma].
|
Internist (Berl)
|
1980
|
0.75
|
|
44
|
Molecular analysis of an ataxia telangiectasia T-cell clone with a chromosomal translocation t(14;18)--evidence for a breakpoint in the T-cell receptor delta-chain gene.
|
Leuk Res
|
1992
|
0.75
|
|
45
|
[The leukemic retinal infiltrate: a rare extramedullary non-occult manifestation of leukemia?].
|
Dtsch Med Wochenschr
|
1984
|
0.75
|
|
46
|
[The Ommaya reservoir as a therapeutic aid in the treatment of malignant diseases in childhood. Indications, technic, results].
|
Kinderarztl Prax
|
1985
|
0.75
|
|
47
|
Clinical aspects on non-cutaneous T-lymphomas.
|
Pathol Res Pract
|
1981
|
0.75
|
|
48
|
[Benzene-associated myelofibrosis at an early stage].
|
Internist (Berl)
|
1990
|
0.75
|
|
49
|
[Blood lymphocyte enzymopenia in patients with chronic lymphatic leukemia].
|
Verh Dtsch Ges Inn Med
|
1978
|
0.75
|
|
50
|
[Brachytherapy after coronary interventions: current state and future perspectives].
|
Z Kardiol
|
2003
|
0.75
|
|
51
|
[Plasmacytoma of the thyroid gland. Case report and review of over 32 cases in the literature].
|
Med Klin (Munich)
|
1988
|
0.75
|
|
52
|
[Foundations and general problems in the therapy of non-Hodgkin lymphomas].
|
Internist (Berl)
|
1980
|
0.75
|
|
53
|
[Diagnosis of primary non-Hodgkin lymphomas of the central nervous system].
|
Fortschr Neurol Psychiatr
|
1984
|
0.75
|
|
54
|
[Catheter break in an implantable central venous infusion system with embolization in the pulmonary artery].
|
Dtsch Med Wochenschr
|
1989
|
0.75
|
|
55
|
[POEMS syndrome. A rare variant of osteosclerotic multiple myeloma with polyneuropathy, organomegaly, endocrinopathy, M-gradient and skin lesions].
|
Med Klin (Munich)
|
1998
|
0.75
|